Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8234379 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 8 Pages |
Abstract
In this favorable subset of Hodgkin's lymphoma patients without disease in or below the hila, 3D-PRT significantly reduced the dose to the breast, lung, and total body. These observed dosimetric advantages might improve the clinical outcomes of Hodgkin's lymphoma patients by reducing the risk of late radiation effects related to low-to-moderate doses in nontargeted tissues.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Bhishamjit S. M.D., Christina B.S., Christopher G. M.S., Debbie C.M.D., Daniel Ph.D, Zuofeng D.Sc., Nancy P. M.D.,